Healthcare Global Enterprises Limited (HCG) - Net Assets
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has net assets worth Rs14.10 Billion INR (≈ $152.51 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs39.23 Billion ≈ $424.21 Million USD) and total liabilities (Rs25.12 Billion ≈ $271.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Healthcare Global Enterprises Limited assets under control for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs14.10 Billion |
| % of Total Assets | 35.95% |
| Annual Growth Rate | 14.86% |
| 5-Year Change | 59.58% |
| 10-Year Change | 187.73% |
| Growth Volatility | 36.31 |
Healthcare Global Enterprises Limited - Net Assets Trend (2011–2026)
This chart illustrates how Healthcare Global Enterprises Limited's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Healthcare Global Enterprises Limited to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Healthcare Global Enterprises Limited (2011–2026)
The table below shows the annual net assets of Healthcare Global Enterprises Limited from 2011 to 2026. For live valuation and market cap data, see Healthcare Global Enterprises Limited market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs14.10 Billion ≈ $152.51 Million |
+42.44% |
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
+14.44% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
-0.49% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
-1.62% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
+23.77% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
+70.09% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
-19.61% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
-9.81% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
+18.14% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
+6.89% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
+120.97% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
-26.44% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
-4.70% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
+34.87% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
+24.38% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Healthcare Global Enterprises Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs1.49 Billion | 11.21% |
| Other Components | Rs11.83 Billion | 88.79% |
| Total Equity | Rs13.32 Billion | 100.00% |
Healthcare Global Enterprises Limited Competitors by Market Cap
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fox-Wizel Ltd
TA:FOX
|
$1.08 Billion |
|
Shandong Kaisheng New Materials Co.Ltd.
SHE:301069
|
$1.08 Billion |
|
ZINKA LOGISTICS SOL LTD
NSE:BLACKBUCK
|
$1.08 Billion |
|
BKI Investment Company Ltd
AU:BKI
|
$1.09 Billion |
|
Anhui Guofeng Plastic Industry Co Ltd
SHE:000859
|
$1.08 Billion |
|
Wuxi Dk Electronic Materials Co Ltd
SHE:300842
|
$1.08 Billion |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
$1.08 Billion |
|
Instalco Intressenter AB
ST:INSTAL
|
$1.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Healthcare Global Enterprises Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 9,224,500,000 to 13,319,700,000, a change of 4,095,200,000 (44.4%).
- Net income of 137,600,000 contributed positively to equity growth.
- New share issuances of 4,488,500,000 increased equity.
- Other comprehensive income decreased equity by 202,820,000.
- Other factors decreased equity by 328,080,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs137.60 Million | +1.03% |
| Share Issuances | Rs4.49 Billion | +33.7% |
| Other Comprehensive Income | Rs-202.82 Million | -1.52% |
| Other Changes | Rs-328.08 Million | -2.46% |
| Total Change | Rs- | 44.39% |
Book Value vs Market Value Analysis
This analysis compares Healthcare Global Enterprises Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 33.16x to 7.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | Rs20.26 | Rs671.75 | x |
| 2012-03-31 | Rs25.02 | Rs671.75 | x |
| 2013-03-31 | Rs46.95 | Rs671.75 | x |
| 2014-03-31 | Rs38.41 | Rs671.75 | x |
| 2015-03-31 | Rs24.86 | Rs671.75 | x |
| 2016-03-31 | Rs58.44 | Rs671.75 | x |
| 2017-03-31 | Rs50.80 | Rs671.75 | x |
| 2018-03-31 | Rs59.75 | Rs671.75 | x |
| 2019-03-31 | Rs54.10 | Rs671.75 | x |
| 2020-03-31 | Rs43.06 | Rs671.75 | x |
| 2021-03-31 | Rs61.34 | Rs671.75 | x |
| 2022-03-31 | Rs64.38 | Rs671.75 | x |
| 2023-03-31 | Rs61.59 | Rs671.75 | x |
| 2024-03-31 | Rs58.81 | Rs671.75 | x |
| 2025-03-31 | Rs65.22 | Rs671.75 | x |
| 2026-03-31 | Rs92.93 | Rs671.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Healthcare Global Enterprises Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.54%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 2.94x
- Recent ROE (1.03%) is above the historical average (-2.85%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 3.68% | 2.94% | 0.55x | 2.27x | Rs-108.06 Million |
| 2012 | -1.58% | -1.25% | 0.48x | 2.61x | Rs-244.54 Million |
| 2013 | -3.71% | -3.11% | 0.48x | 2.50x | Rs-388.54 Million |
| 2014 | -13.48% | -7.88% | 0.66x | 2.61x | Rs-619.30 Million |
| 2015 | 0.46% | 0.16% | 0.69x | 4.16x | Rs-173.89 Million |
| 2016 | -0.34% | -0.25% | 0.56x | 2.45x | Rs-440.43 Million |
| 2017 | 5.12% | 3.17% | 0.57x | 2.83x | Rs-210.93 Million |
| 2018 | 3.98% | 2.47% | 0.58x | 2.80x | Rs-309.87 Million |
| 2019 | -5.20% | -2.53% | 0.59x | 3.47x | Rs-724.62 Million |
| 2020 | -27.99% | -9.74% | 0.49x | 5.91x | Rs-1.45 Billion |
| 2021 | -27.75% | -19.09% | 0.50x | 2.92x | Rs-2.63 Billion |
| 2022 | 6.17% | 3.84% | 0.63x | 2.55x | Rs-332.96 Million |
| 2023 | 3.41% | 1.73% | 0.73x | 2.69x | Rs-567.04 Million |
| 2024 | 5.83% | 2.52% | 0.71x | 3.28x | Rs-344.23 Million |
| 2025 | 4.81% | 2.00% | 0.63x | 3.84x | Rs-478.35 Million |
| 2026 | 1.03% | 0.54% | 0.65x | 2.94x | Rs-1.19 Billion |
Industry Comparison
This section compares Healthcare Global Enterprises Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $26,599,459,667
- Average return on equity (ROE) among peers: 6.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Healthcare Global Enterprises Limited (HCG) | Rs14.10 Billion | 3.68% | 1.78x | $1.08 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $65.31 Billion | 12.54% | 1.21x | $13.71 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $11.42 Billion | 8.03% | 0.87x | $4.56 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $1.01 Billion | 7.52% | 1.28x | $145.48 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $13.56 Billion | 14.24% | 0.40x | $226.19 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $5.67 Billion | -8.43% | 0.98x | $3.55 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $527.27 Million | -0.45% | 0.07x | $26.42 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $93.81 Billion | 11.47% | 0.62x | $11.58 Billion |
| Max India Limited (MAXIND) | $14.21 Billion | -2.98% | 0.65x | $99.20 Million |
| Global Health Limited (MEDANTA) | $33.88 Billion | 14.21% | 0.41x | $4.20 Billion |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more